These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11062531)

  • 21. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
    Deml L; Bojak A; Steck S; Graf M; Wild J; Schirmbeck R; Wolf H; Wagner R
    J Virol; 2001 Nov; 75(22):10991-1001. PubMed ID: 11602739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
    Pal R; Kalyanaraman VS; Nair BC; Whitney S; Keen T; Hocker L; Hudacik L; Rose N; Mboudjeka I; Shen S; Wu-Chou TH; Montefiori D; Mascola J; Markham P; Lu S
    Virology; 2006 May; 348(2):341-53. PubMed ID: 16460776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV and SIV CTL escape: implications for vaccine design.
    Goulder PJ; Watkins DI
    Nat Rev Immunol; 2004 Aug; 4(8):630-40. PubMed ID: 15286729
    [No Abstract]   [Full Text] [Related]  

  • 25. New finding on immune response to HIV Tat may contribute to vaccine, treatment.
    James JS
    AIDS Treat News; 2000 Sep; (351):4. PubMed ID: 12173551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine advance: monkeys still infected, but protected from illness.
    James JS
    AIDS Treat News; 2000 Oct; (353):2-3. PubMed ID: 12173554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macaque models for AIDS vaccine development.
    Johnson RP
    Curr Opin Immunol; 1996 Aug; 8(4):554-60. PubMed ID: 8794019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A winding road towards an HIV vaccine.
    Rowland-Jones S
    Eur J Immunol; 2008 Jan; 38(1):13-4. PubMed ID: 18286707
    [No Abstract]   [Full Text] [Related]  

  • 29. Prototype AIDS vaccine works in monkeys.
    Am Pharm; 1990 Feb; NS30(2):5. PubMed ID: 2106250
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS vaccines: is older better?
    Cohen J
    Science; 1992 Dec; 258(5090):1880-1. PubMed ID: 1470911
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV vaccines: prospects and challenges.
    Baltimore D; Heilman C
    Sci Am; 1998 Jul; 279(1):98-103. PubMed ID: 9648305
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS: the evolving story.
    Phillips RE; Oxenius A; Price DA; Bangham CR
    Trends Microbiol; 2000 Apr; 8(4):147-8. PubMed ID: 10754566
    [No Abstract]   [Full Text] [Related]  

  • 33. Gene transfer as a new mode of vaccination: implications for HCV.
    McDonnell WM
    Hepatology; 1993 Sep; 18(3):696-8. PubMed ID: 8395461
    [No Abstract]   [Full Text] [Related]  

  • 34. First UK trial of AIDS vaccine approved.
    Concar D
    Nature; 1990 Jul; 346(6282):303. PubMed ID: 2197559
    [No Abstract]   [Full Text] [Related]  

  • 35. [Betting on the International AIDS Vaccine Initiative: an anti-AIDS vaccine in 10 years].
    Manus JM
    Rev Infirm; 1999 Oct; (53):11. PubMed ID: 10797793
    [No Abstract]   [Full Text] [Related]  

  • 36. First AIDS vaccine: better than nothing.
    Park A
    Time; 1998 Jun; 151(23):66. PubMed ID: 10181037
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vaccines against AIDS finally in sight? Vaccination campaigns in China and Uganda in preliminary stages].
    Wolf HJ
    Fortschr Med; 1995 Nov; 113(31):20, 22. PubMed ID: 8529980
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV-specific cytotoxic T lymphocytes and their possible implications in the future vaccine against AIDS.
    Langlade-Demoyen P; Hoffenbach A
    Res Immunol; 1989 Jan; 140(1):95-9; discussion 119-20. PubMed ID: 2567045
    [No Abstract]   [Full Text] [Related]  

  • 39. Changing paradigms for an HIV vaccine.
    Schultz AM
    Adv Exp Med Biol; 1996; 397():79-90. PubMed ID: 8718586
    [No Abstract]   [Full Text] [Related]  

  • 40. Of AIDS and altruism. In theory, a new kind of vaccine could halt the epidemic.
    Burr C
    US News World Rep; 1998 Apr; 124(13):60-1. PubMed ID: 10177909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.